2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 40.268 | 42.371 | 49.710 | 61.833 | 70.485 | 82.958 | 48.710 | 50.108 | 59.899 | 79.107 |
Total Income - EUR | 40.440 | 42.984 | 50.067 | 62.066 | 70.972 | 83.416 | 49.248 | 52.398 | 60.482 | 79.366 |
Total Expenses - EUR | 17.462 | 25.176 | 17.703 | 21.307 | 20.943 | 19.998 | 18.976 | 18.363 | 19.582 | 21.248 |
Gross Profit/Loss - EUR | 22.977 | 17.808 | 32.363 | 40.759 | 50.029 | 63.418 | 30.272 | 34.035 | 40.900 | 58.118 |
Net Profit/Loss - EUR | 21.764 | 16.518 | 31.863 | 40.139 | 49.319 | 62.584 | 29.817 | 33.511 | 40.307 | 57.341 |
Employees | 2 | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Ipmed S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 16.634 | 15.044 | 12.172 | 5.258 | 5.161 | 4.733 | 5.593 | 6.547 | 6.027 | 5.959 |
Current Assets | 44.306 | 63.118 | 23.408 | 37.761 | 47.310 | 60.981 | 28.087 | 30.946 | 67.652 | 54.630 |
Inventories | 1.837 | 1.852 | 2.320 | 1.802 | 1.769 | 1.735 | 1.702 | 1.664 | 1.669 | 1.664 |
Receivables | 1.527 | 1.506 | 1.135 | 1.859 | 2.018 | 3.265 | 1.327 | 1.342 | 31.988 | 2.835 |
Cash | 25.154 | 30.858 | 4.254 | 3.767 | 43.345 | 4.144 | 3.849 | 3.452 | 3.292 | 6.326 |
Shareholders Funds | 59.156 | 76.169 | 31.916 | 40.423 | 49.371 | 62.634 | 29.866 | 33.560 | 40.356 | 57.389 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 1.784 | 1.993 | 3.726 | 2.596 | 3.101 | 3.080 | 3.960 | 3.934 | 33.323 | 3.199 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Ipmed S.r.l.